UBS Group AG - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 61 filers reported holding OVID THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$184,731
+13.5%
48,107
-3.1%
0.00%
Q2 2023$162,773
+249.2%
49,626
+174.6%
0.00%
Q1 2023$46,618
+49.2%
18,069
+7.6%
0.00%
Q4 2022$31,235
-13.2%
16,793
-12.4%
0.00%
Q3 2022$36,000
+5.9%
19,161
+20.2%
0.00%
Q2 2022$34,000
-27.7%
15,945
+6.3%
0.00%
Q1 2022$47,000
-24.2%
15,000
-22.2%
0.00%
Q4 2021$62,000
+24.0%
19,277
+28.5%
0.00%
Q3 2021$50,000
-15.3%
15,0000.0%0.00%
Q2 2021$59,000
-27.2%
15,000
-25.1%
0.00%
Q1 2021$81,000
-96.6%
20,037
-98.1%
0.00%
-100.0%
Q4 2020$2,378,000
-8.0%
1,029,593
+128.7%
0.00%0.0%
Q3 2020$2,584,000
+163.7%
450,271
+238.6%
0.00%
Q2 2020$980,000
+58.1%
132,990
-36.1%
0.00%
Q1 2020$620,000
+3547.1%
207,964
+5127.9%
0.00%
Q4 2019$17,000
+30.8%
3,978
-42.0%
0.00%
Q2 2019$13,000
-45.8%
6,860
-32.1%
0.00%
Q4 2018$24,000
+26.3%
10,101
+206.5%
0.00%
Q3 2018$19,000
-17.4%
3,296
+10.8%
0.00%
Q2 2018$23,000
+1050.0%
2,974
+1210.1%
0.00%
Q4 2017$2,000
-86.7%
227
-87.2%
0.00%
Q3 2017$15,0001,7700.00%
Other shareholders
OVID THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
TLS Advisors LLC 1,380,346$3,51618.08%
Madison Avenue Partners, LP 3,104,603$8,009,8761.72%
BVF INC/IL 6,851,051$17,675,7120.65%
CHI Advisors LLC 864,822$2,231,2410.59%
EcoR1 Capital, LLC 6,117,400$15,782,8920.51%
Rubric Capital Management LP 7,001,124$18,062,9000.47%
Artal Group S.A. 2,500,000$6,4500.38%
Tejara Capital Ltd 118,791$306,4810.16%
DCF Advisers, LLC 68,264$176,1200.11%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 827,580$2,135,1560.06%
View complete list of OVID THERAPEUTICS INC shareholders